Search

Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.

… Wednesday, December 19, 2012 Summary Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs. Metastasis , the process by which some tumors spread from their site of origin to other body

After an extensive nationwide search, Memorial Sloan Kettering Cancer Center (MSK) announced today that Lisa M. DeAngelis has been named Physician-in-Chief and Chief Medical Officer. A leading expert in brain cancer, Dr. DeAngelis previously served as Chair of the Department of Neurology and was co-founder of MSK’s Brain Tumor Center during her 30-plus-year tenure at the institution.

… Tuesday, September 10, 2019 Lisa M. DeAngelis Has Been Named Physician-in-Chief and Chief Medical Officer of MSK Lisa M. DeAngelis Has Been Named Physician-in-Chief and Chief Medical Officer of MSK After an extensive nationwide search, Memorial Sloan Kettering Cancer Center (MSK) announced today that

During the upcoming ASCO Virtual Scientific Program, MSK Medical Oncologist Zsofia K. Stadler, MD, will present a study where she and her team sought to assess the clinical utility of germline mutation profiling for targeted therapeutic interventions in a pan-cancer patient population, or a population with similarities and differences among the genomic and cellular alterations found across their diverse tumor types.

… Friday, May 29, 2020 During the American Society of Clinical Oncology (ASCO) Virtual Scientific Program , Memorial Sloan Kettering (MSK) Medical Oncologist Zsofia K. Stadler, MD , will present a study where she and her team sought to assess the clinical utility of germline mutation profiling for targeted

The David H. Koch Center for Cancer Care has recently been recognized by a number of industry leaders for its innovative and resilient design, some of the many features that put the 750,000 square foot facility in a class of its own.

… Friday, June 5, 2020 It’s been six months since members of the MSK Boards of Overseers and Managers, hospital leadership, and local elected officials joined together to celebrate the opening of the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center . Recently, the facility

Investigators at Memorial Sloan Kettering Cancer Center have found new clues about how metastatic cancer can form long after a primary tumor has been removed.

… Monday, December 1, 2008 Summary Investigators at Memorial Sloan Kettering Cancer Center have found new clues about how metastatic cancer can form long after a primary tumor has been removed. Investigators at Memorial Sloan Kettering Cancer Center have found new clues about how metastatic cancer can

Department of Surgery Chair Jeffrey Drebin discusses MSK’s approach to robotic surgery in response to a recent FDA advisory.

… Friday, March 8, 2019 Summary Jeffrey Drebin, Chair of the Department of Surgery, discusses MSK’s approach to robotic surgery and the importance of having a skilled surgeon for cancer operations. On February 28, the US Food and Drug Administration released a statement cautioning about the use of robotic

May 23, 2007 NEW YORK - The Bright Horizons Foundation for Children, Memorial Sloan Kettering Cancer Center (MSKCC), Abyssinian Development Corporation (ADC), and Community Playthings today cut ribbons to officially open Harlem's first Bright Space center for homeless children at Abyssinian House, a Tier II transitional residence serving the families of Harlem.

… Wednesday, May 23, 2007 The Bright Horizons Foundation for Children, Memorial Sloan Kettering Cancer Center (MSKCC), Abyssinian Development Corporation (ADC), and Community Playthings today cut ribbons to officially open Harlem’s first Bright Space center for homeless children at Abyssinian House, a

The research focused on sclerosing stromal tumor, a rare, benign ovarian tumor that is not cancer but can be misdiagnosed as cancer.

… Monday, January 27, 2020 Summary Investigators are studying a rare ovarian tumor called sclerosing stromal tumor, a benign tumor that can be misdiagnosed as cancer. As research has revealed more about the genomics of cancer, it’s changed the way that doctors think about the disease. There is not a single

A study led by researchers at Memorial Sloan Kettering and New York University has shown that TET2 loss enhances the function of blood stem cells, causing them to renew themselves more efficiently than normal blood stem cells.

… Saturday, October 1, 2011 Summary A study led by researchers at Memorial Sloan Kettering and New York University has shown that TET2 loss enhances the function of blood stem cells, causing them to renew themselves more efficiently than normal blood stem cells. In 2008, two research groups in Europe made

In 2023, the MSK Giving community raised a record-breaking $1 billion — 100% of which will support our mission of ending cancer for life.

… Monday, June 10, 2024 In 2023, the MSK Giving community raised a record-breaking $1 billion — 100% of which will support our Memorial Sloan Kettering Cancer Center (MSK) mission of ending cancer for life . Every single member of the MSK Giving community was key to this historic success. “We are the most